Genitourinary Radiology

PI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRI

By Kate Madden Yee

PI-RADS v2.1 was developed by the ACR and the European Society of Urogenital Radiology (ESUR) and released in 2019.

October 15, 2025

ASTRO: Trial suggests postoperative RT in high-risk bladder cancer

By Liz Carey

Moderate doses of radiation therapy (RT) after bladder removal surgery cut rates of new pelvic cancer, according to researchers.

September 30, 2025

ACS: Cancer survival rates are lower in rural areas

By Kate Madden Yee

The research also reported lower cancer survival rates for Blacks compared to whites, underscoring "disparities in receipt of care."

September 24, 2025

Disparities persist in UFE access, utilization

By Kate Madden Yee

Disparities persist across the U.S. in access to and use of uterine fibroid embolization (UFE) compared with surgical treatments.

September 16, 2025

Olympus releases ENT, urology imaging platform

By AuntMinnie.com staff writers

Olympus has launched its new Visera S OTV-S500 imaging platform for ENT and urology applications.

September 2, 2025

How multiparametric MRI can improve prostate cancer detection

By Kate Madden Yee

The study results could help further clarify the modality's benefits for this indication.

August 12, 2025

AI improves diagnostic consistency in bpMRI for prostate imaging

By Kate Madden Yee

The results contribute to a growing body of literature that supports the use of AI with prostate cancer imaging.

July 17, 2025

New OPTN policy will improve patient access to CEUS for liver cancer

By AuntMinnie.com staff writers

A new policy published by the OPTN will expand patient access to advanced ultrasound imaging and transplant options for liver cancer.

July 14, 2025

SNMMI: Botox may prevent debilitating dry mouth for some mCRPC patients

By Liz Carey

Research presented at the meeting addressed salivary gland toxicity associated with uptake of PSMA-targeted radioligand therapy.

June 24, 2025

Nuclidium presents phase I results for PSMA tracer at SNMMI

By AuntMinnie.com staff writers

Nuclidium presented positive data from the phase I clinical trial of its new copper-61 PET imaging agent for prostate cancer.

June 24, 2025

Archeus Technologies nets ART-101 IND FDA clearance

By AuntMinnie.com staff writers

The company has received U.S. Food and Drug Administration (FDA) clearance of its ART-101 Investigational New Drug (IND) application.

June 20, 2025

Clarity highlights first patient imaged in Amplify trial

By AuntMinnie.com staff writers

Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.

May 29, 2025

Page 1 of 93

Next Page